DL-Valine (CAS 516-06-3, C₅H₁₁NO₂, molar mass 117.15 g/mol) is the racemic mixture of D- and L-valine, supplied as a white crystalline powder with an assay that is typically controlled at 98.5% to 101.0% on the dried basis. The product is optically inactive by definition; a 10% aqueous solution shows no significant angular rotation. Commercial model nomenclature is not harmonized, but suppliers frequently encode the minimum assay in the designation—for example, a feed-grade lot may be labelled 98.5% and a synthesis-grade lot 99.0%—while the suffix denotes application-specific metal and residue limits rather than enantiomeric purity. Because the racemate is prepared by chemical condensation of isobutyraldehyde through Strecker or Bucherer–Bergs hydantoin routes, the product does not carry the fermentation-broth residues associated with L-valine produced by Corynebacterium glutamicum. The molecule contains two ionizable centres with pK_a values of approximately 2.29 (carboxyl) and 9.72 (amino); the isoelectric point is therefore near 5.96, and solubility is lowest in this neutral range. Loss on drying is generally specified at ≤0.20% after 105 °C for 2 h, and residue on ignition is controlled at ≤0.10% by ashing at 600 °C. Heavy metal limits are commonly ≤10 mg/kg as lead when the material is intended for feed or pharmaceutical intermediates, and chloride or sulfate limits may be added for synthesis-grade material. The nitrogen content is 11.96%, corresponding to a crude protein equivalent of approximately 74.8% using the 6.25 factor. Because the manufacturing route is achiral, enantiomeric purity is not a release parameter; the product is specified by chemical purity, moisture, ash, and metal profile. A 10% slurry in deionized water at 20 °C typically presents a pH between 5.5 and 7.0, but this range is supplier-specific and should not be used as a primary identity test.

What Distinguishes the Racemate from L-Valine and D-Valine in Bulk Specification?

The principal specification difference is optical rotation. L-Valine (CAS 72-18-4) is the biologically active enantiomer and shows a specific rotation of +26.5° to +29.0° (c = 5, 6 N HCl, 20 °C). D-Valine (CAS 640-68-6) is the mirror-image isomer with negative rotation of similar magnitude. DL-Valine has no measurable rotation and is therefore excluded from polarimetric identity criteria. The synthetic route to the racemate delivers an exact 1:1 molar mixture of D- and L-isomers; the material is not a simple blend of separately produced enantiomers unless post-synthesis crystallization is used. Table 1 summarizes the bulk comparison.

Because the racemate is chemically synthesized from achiral starting materials, enantiomeric purity is generally not reported. This distinguishes DL-valine from fermentation-derived L-valine, where the D-isomer is controlled to ensure stereochemical purity. For cost-sensitive feed applications, DL-valine can provide the same total valine mass, but the D-isomer fraction must be evaluated independently for biological value. Published data for D-valine bioefficacy in monogastric species is limited; therefore feed-grade DL-valine is not automatically interchangeable with feed-grade L-valine on an equal-mass basis. The synthetic material also differs in bulk morphology: crystalline DL-valine has a denser, harder particle structure than spray-dried L-valine fermentation product, and this difference affects blending, dusting, and dissolution behaviour in premix and liquid-feed systems. In near-infrared quality control, a calibration generated for fermentation-grade L-valine cannot be transferred directly to DL-valine because the water band positions and particle-scattering baseline are not identical.

Release Specification and Compliance Matrix

Release documentation for DL-valine intended for feed or industrial synthesis typically includes identity, assay, loss on drying, residue on ignition, heavy metals, and nitrogen content. The following matrix aligns the tests with standard method designations and representative limits. Where a supplier uses an internal method, the certificate should state the equivalent pharmacopoeial or ISO method to permit audit against the limits in Table 2.

Residue on ignition is a discriminating parameter for synthesis-grade material because non-volatile inorganic contamination can poison downstream hydrogenation or coupling catalysts. In peptide synthesis, a residue on ignition above 0.10% is often rejected, particularly when the amino acid is to be converted to N-protected derivatives without prior recrystallization. Heavy metal limits below 10 mg/kg are required where the downstream product is a pharmaceutical intermediate; lower limits may be negotiated with the supplier for chiral resolution work. Solubility in aqueous process streams is pH-dependent: the molecule is zwitterionic in the neutral range, and dissolution is accelerated below pH 2 or above pH 10. The pK_a values of valine are approximately 2.29 and 9.72, which determines charge state in ion-exchange purification and salt formation. The absence of a fermentation matrix also means that bacterial endotoxin and residual DNA are not typical release parameters for chemically synthesized DL-valine, whereas they are relevant for cell-culture-grade L-valine.

In poultry and swine rations, DL-valine is priced as a source of branched-chain amino acid nitrogen, but the biological value resides almost entirely in the L-isomer. Formulation software should assign DL-valine a valine equivalence of 50% on a molar and mass basis because the racemate contains exactly half L-valine. The crude protein contribution can be calculated from the 11.96% nitrogen content and the standard 6.25 nitrogen-to-protein factor. In reduced-protein broiler diets supplemented with L-lysine, DL-methionine, L-threonine, and L-isoleucine, valine may become the next limiting amino acid; replacing the racemate for L-valine without correcting for the D-isomer fraction will under-supply the target valine level. Published data on the conversion of D-valine to L-valine in pigs and poultry is limited, and the conservative approach is to treat the D-isomer as biologically unavailable. For ruminant applications, the free amino acid is subject to rumen degradation unless the material is coated or otherwise protected; the need for protection is identical to that for L-valine and does not change with racemic identity. In high-moisture feed blocks, the amino acid can participate in Maillard browning with reducing sugars; the premix moisture should be kept below 10% and reducing-sugar carriers should be avoided or pre-dried to 12% moisture or lower before mixing.

When DL-Valine Is Used as a Chiral Building Block

DL-Valine enters synthetic pathways primarily as a raw material for racemic resolution or as an intermediate in the manufacture of valine-derived heterocycles, carbamates, and agrochemical actives. In solid-phase peptide synthesis, direct use of the racemate without resolution is restricted to positions where racemization is acceptable or where the resulting diastereomers are separated chromatography. The presence of equimolar D- and L-valine can alter crystallization behavior of the final peptide; diastereomeric salts may show different solubility in acetonitrile-water systems. For resolution, the racemate can be treated with a chiral resolving agent or selective acylase; the unreactive isomer is recovered and racemized for recycle. Process-scale resolution requires tight control of pH and temperature because valine has pK_a values of approximately 2.29 (carboxyl) and 9.72 (amino). Equipment selection for resolution steps typically includes glass-lined reactors with internal cooling coils because the hydrochloride formation is exothermic; published data for specific heat of reaction in DL-valine hydrochloride crystallization is limited. The racemate is also used to prepare N-acetyl-DL-valine, which is then resolved by acylase I to L-valine and N-acetyl-D-valine; the D-isomer is racemized in a separate process step at elevated temperature and alkaline pH. This recycling loop is a standard cost lever in industrial amino acid operations, but the exact racemization yield depends on catalyst and residence time.

Is the Racemate Suitable for Chemically Defined Cell Culture Media?

DL-Valine is generally not a direct substitute for L-valine in chemically defined eukaryotic cell culture media. Eukaryotic protein synthesis uses the L-isomer, and the D-isomer is not recognized by the valyl-tRNA synthetase. The D-isomer can also compete for transport at the L-type amino acid transporter, potentially reducing net L-valine uptake at high racemate concentration. Most commercial media formulations specify L-valine at concentrations between 0.08 mM and 0.4 mM; adding DL-valine at double the mass would supply the same L-valine concentration but would also introduce an equal D-valine load. Published data for specific cell-line responses to D-valine is limited; some microbial and plant cultures tolerate the racemate, while sensitive eukaryotic lines may show growth inhibition above 0.5 mM total racemate. Consequently, DL-valine is not used in GMP media unless specifically validated. For microbial fermentation, the racemate can be used if the organism expresses a racemase or if the D-isomer is catabolized; otherwise L-valine is preferred.

Thermal stability studies under inert atmosphere indicate that DL-valine does not melt without decomposition; the melting point is reported above 298 °C with decomposition. This high thermal stability makes it compatible with standard feed pelleting temperatures of 70–90 °C, but residence time in conditioner above 85 °C should be limited if the premix contains reducing sugars because browning accelerates. In synthetic chemistry, the high decomposition point permits use in reactions up to 120 °C in polar aprotic solvents, provided the amino group is protected. Published data for thermal degradation kinetics of unprotected DL-valine in feed matrices is limited.

For feed-grade blending and bulk handling, the crystalline powder is typically added to a premix step before final feed manufacturing. The particle-size distribution of synthetic DL-valine should be matched to the carrier to prevent segregation in ribbon mixers and pneumatic conveying lines. Sieve analysis is normally reported against 20 mesh and 80 mesh fractions; if the 80-mesh fraction is above 90%, dust control becomes a critical operational boundary. Bulk bags should be stored under dry conditions below 60% relative humidity to limit caking; the material is not classified as a hazardous product under typical REACH or GHS transport criteria, but local feed-additive registrations must be confirmed before use. Unlike fermentation-derived L-valine, the synthetic racemate does not carry a microbial protein matrix, so filter-clogging behavior in liquid feed systems is lower; however, published data for this specific configuration is limited. In aqueous feed supplements, preparations should be used within 24 h unless an approved preservative is present, because free amino acids support microbial growth under non-sterile ambient conditions.

From a regulatory perspective, DL-valine and L-valine are not automatically interchangeable. Regional feed-additive authorizations may list L-valine produced by specified microbial strains and not the synthetic racemate. A manufacturer submitting a feed formulation with DL-valine should confirm the local positive list before use. In pharmaceutical intermediates, the racemate is accepted only when the downstream route includes chiral resolution or when the final product is racemic. Material safety data sheets generally classify DL-valine as a non-dangerous solid, but dust exposure limits for amino acid powders may apply under occupational hygiene codes; local workplace exposure limits should be checked.